Intellectual Property India Publishes Patent Application for 'Prmt5 Inhibitors And Uses Thereof' Filed by Gilead Sciences, Inc.

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517066407 A) filed by Gilead Sciences, Inc., Foster City, U.S.A., on July 11, for 'prmt5 inhibitors and uses thereof.'

Inventor(s) include Armstrong, Megan K; Chin, Elbert; Chou, Chienhung; Debien, Laurent P.; Farr, Joshua D.; Gupta, Pancham Lal; Hung, Chao-I; Mitchell, Michael L.; Mukherjee, Prasenjit K.; Nguyen, Shaina V.; Notte, Gregory T.; Roa, Daniel; Schrier, Adam J.; and Yang, Zheng-Yu.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates generally to compounds that inhibit PRMT5. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through inhibiting PRMT5. The disclosure further relates to the use of the compounds for the treatment of a disease or condition associated with chromosome 9p21 deletion or MTAP null. The disclosure further relates to the use of the compounds for the treatment of cancers."

The patent application was internationally filed on Dec. 20, 2023, under International application No.PCT/US2023/085207.

Disclaimer: Curated by HT Syndication.